Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-040061

Chief Financial Officer sold 294 shares at $12.12 ($3,563)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2023-06-27 Sale −294 $12.12 $3,563 147,829 D
Open-market sales · 294 sh · avg $12.12 · $3,563
Loading xslF345X04/doc4.xml…